CARD8 rs2043211 polymorphism is associated with gout in a Chinese male population

Ying Chen1, Xianfeng Ren, Changgui Li

  • 1Department of Endocrinology, Affiliated Hospital of Qingdao University, Qingdao, China.

Insights

Genetic factors influence gout development. This study found a significant association between the CARD8 rs2043211 polymorphism and gout susceptibility in Chinese Han males, impacting triglyceride levels and blood pressure.

Area of Science:

  • Genetics
  • Rheumatology
  • Molecular Biology

Background:

  • Gout is a complex disease with suspected genetic underpinnings.
  • Previous research indicates a role for genetic factors in gout pathogenesis.
  • The CARD8 rs2043211 polymorphism is a candidate gene for investigation.

Purpose of the Study:

  • To investigate the genetic association between the CARD8 rs2043211 polymorphism and gout.
  • To explore genotype-phenotype correlations in relation to gout.

Main Methods:

  • A case-control study involving 396 male gout patients and 403 healthy controls.
  • Genotyping performed using TaqMan SNP Genotyping Assays.
  • Association analysis conducted using the chi-squared test and genotype-phenotype analysis.

Main Results:

  • The CARD8 rs2043211 polymorphism genotype distribution was in Hardy-Weinberg equilibrium in controls (P = 0.27).
  • A significant difference in genotype distribution was observed between gout cases and controls (P = 0.017).
  • The CARD8 rs2043211 polymorphism was significantly associated with gout under a recessive model (OR = 0.65, 95%CI 0.47-0.88, P = 0.006).
  • Carriers of the TT genotype exhibited higher triglyceride levels, elevated systolic blood pressure, and an increased risk of renal calculus compared to AA genotype carriers.

Conclusions:

  • The CARD8 rs2043211 polymorphism is significantly associated with gout susceptibility in Chinese Han males.
  • This polymorphism may influence metabolic and clinical features associated with gout.

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
20.2K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
129
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
17.0K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
71
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
158
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
119